Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cervical Cancer

Free Subscription 27.10.2025 1 3 Biotech 1 Am J Cancer Res 1 Am J Transl Res 1 Ann Epidemiol 1 Arch Gynecol Obstet 1 Bioorg Med Chem Lett 2 BMC Public Health 1 BMC Womens Health 1 BMJ Glob Health 4 Brachytherapy 1 Cancer Invest 1 Cell Rep Med 1 Chin Med J (Engl) 1 Clin Med Insights Oncol 1 Cureus 1 Eur J Pharmacol 1 Exp Cell Res 1 Exp Clin Transplant 1 Fam Pract 1 Front Cell Dev Biol 1 Front Cell Infect Microbiol 1 Front Endocrinol (Lausanne) 1 Front Microbiol 2 Front Mol Biosci 1 Front Oncol 2 Front Pharmacol 1 Funct Integr Genomics 1 Gynecol Oncol Rep 1 Health Care Women Int 1 J Biomed Sci 1 J Formos Med Assoc 1 J Natl Med Assoc 1 J Virol Methods 1 JAMA Netw Open 1 JCO Glob Oncol 2 Lancet Glob Health 2 Med Oncol 1 Mod Pathol 1 Mol Cancer 1 Mol Carcinog 1 Naunyn Schmiedebergs Arch Pharmacol 1 Noncoding RNA Res 1 PEC Innov 1 Philos Ethics Humanit Med 1 Public Health 2 Radiother Oncol 1 Rev Esp Patol 4 Sci Rep 1 Strahlenther Onkol 1 Vaccine 1 Virchows Arch 2 Virol J 1 World J Surg Oncol 1 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

3 Biotech

1. PUROHIT N, Mishra Y, Hazarika P, Gopalakrishnan AV, et al
   Pathways to precision medicine in cervical cancer: a comprehensive review of small molecule inhibitors, biomarkers and computational approaches.
   3 Biotech. 2025;15:390.
   PubMed         Abstract available
   
   

   
   Am J Cancer Res

2. WANG Y, Qi C, Hao M
   Development of a prognostic model for cervical cancer based on inflammation-related gene signatures and immune microenvironment regulation.
   Am J Cancer Res. 2025;15:3933-3946.
   PubMed         Abstract available
   
   

   
   Am J Transl Res

3. YAO D, Ding H, Wang W
   Efficacy and prognosis of concurrent chemoradiotherapy in the management of recurrent cervical cancer: a retrospective study.
   Am J Transl Res. 2025;17:7021-7029.
   PubMed         Abstract available
   
   

   
   Ann Epidemiol

4. JONES J
   Screening learning module: Huang et al (2025), association between screening history and prognosis of cervical carcinoma in situ and invasive cervical cancer - A population-based cohort study.
   Ann Epidemiol. 2025;109:143-144.
   PubMed         Abstract available
   
   

   
   Arch Gynecol Obstet

5. AIOB A, Gumin D, Sharon A, Lowenstein L, et al
   Mini-laparotomic-assisted laparoscopic radical hysterectomy: an innovative technique for cervical cancer surgery-a case series.
   Arch Gynecol Obstet. 2025 Oct 22. doi: 10.1007/s00404-025-08224.
   PubMed         Abstract available
   
   

   
   Bioorg Med Chem Lett

6. ZHU EJ, Bu XS, Yue Y, Hou YS, et al
   Design, synthesis and biological evaluation of novel HIF-1alpha PROTACs degrader as potent anti-cervical cancer agents.
   Bioorg Med Chem Lett. 2025 Oct 21:130443. doi: 10.1016/j.bmcl.2025.130443.
   PubMed         Abstract available
   
   

   
   BMC Public Health

7. JOHN A, Abbah AP, Sandoy IF
   Associations of socioeconomic factors with parents' awareness and acceptability of HPV vaccination in sub-Saharan Africa - a systematic review and meta-analysis.
   BMC Public Health. 2025;25:3525.
   PubMed         Abstract available
   
   
8. VANDYCK-SEY PNEW, Burchett HED
   Efforts to increase uptake of cervical cancer screening in the absence of a national programme in Ghana: a qualitative study of stakeholders' experience.
   BMC Public Health. 2025;25:3530.
   PubMed         Abstract available
   
   

   
   BMC Womens Health

9. CARASSITI R, Jentschke M, Soergel P, Hilal Z, et al
   Cervical cancer screening by co-testing in women 35 years and older: an analysis of the 1st round of screening in Germany.
   BMC Womens Health. 2025;25:498.
   PubMed         Abstract available
   
   

   
   BMJ Glob Health

10. PACE LE, Uwihaye JD, Mukandayisenga V, Fata AM, et al
    Early experience scaling up a breast cancer early detection initiative integrated with cervical cancer screening in Rwanda.
    BMJ Glob Health. 2025;10:e021235.
    PubMed         Abstract available
    
    

    
    Brachytherapy

11. LEMOINE L, Adam V, Salleron J, Cuisinier C, et al
    Randomized trial comparing hypnosis versus standard management on patient anxiety and pain during pelvic brachytherapy applicator removal.
    Brachytherapy. 2025;24:854-862.
    PubMed         Abstract available
    
    
12. RAJAN SS, Ning MS, Jacobson M, Simiele SJ, et al
    Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancers.
    Brachytherapy. 2025;24:844-853.
    PubMed         Abstract available
    
    
13. KIM H, Deng W, Zamarin D, Xiao Y, et al
    Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer.
    Brachytherapy. 2025 Oct 16:S1538-4721(25)00312.
    PubMed         Abstract available
    
    
14. TRUONG R, Moore LC, Mitra A, Kallis K, et al
    Integration of single-click, AI-based brachytherapy auto-planning for cervical cancer within a treatment planning system.
    Brachytherapy. 2025 Oct 22:S1538-4721(25)00297.
    PubMed         Abstract available
    
    

    
    Cancer Invest

15. KAMBLE P, Dubey K, Mukherjee A, Jain R, et al
    Decoding Cervical Cancer Biomarkers: An Integrated Framework of Bioinformatics, Machine Learning, and Experimental Confirmation.
    Cancer Invest. 2025 Oct 22:1-21. doi: 10.1080/07357907.2025.2575338.
    PubMed         Abstract available
    
    

    
    Cell Rep Med

16. MA Y, Lin S, Chen Q, Xue J, et al
    Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study.
    Cell Rep Med. 2025;6:102396.
    PubMed         Abstract available
    
    

    
    Chin Med J (Engl)

17. FAN P, Dong D, Feng Y, Zhu X, et al
    Single-cell analysis identifies PI3+S100A7+keratinocytes in early cervical squamous cell carcinoma with HPV infection.
    Chin Med J (Engl). 2025;138:2615-2630.
    PubMed         Abstract available
    
    

    
    Clin Med Insights Oncol

18. LI Z, Lin Z, Qin P, Xiao R, et al
    Construction of a Risk-Prediction Model for Severe Bone Marrow Suppression During Radiotherapy in Cervical Cancer Patients.
    Clin Med Insights Oncol. 2025;19:11795549251380662.
    PubMed         Abstract available
    
    

    
    Cureus

19. BONALA SR, Subramanian BV, Venati C, Raja SA, et al
    Long-Term Outcomes of Simultaneous Integrated Boost in Node-Positive Cervical Cancer: A Single-Institution Retrospective Study.
    Cureus. 2025;17:e94828.
    PubMed         Abstract available
    
    

    
    Eur J Pharmacol

20. WANG L, Li W, Zhu X, Zhao B, et al
    The role of bromodomain-containing protein 4 in the replication human papillomavirus, apoptosis, proliferation and migration of cervical cancer cells.
    Eur J Pharmacol. 2025 Oct 16:178261. doi: 10.1016/j.ejphar.2025.178261.
    PubMed         Abstract available
    
    

    
    Exp Cell Res

21. JIA L, Cui X, Li X, Li R, et al
    Integrative multi-omics analysis identifies mitochondria- and ferroptosis-related prognostic genes in cervical cancer.
    Exp Cell Res. 2025 Oct 15:114796. doi: 10.1016/j.yexcr.2025.114796.
    PubMed         Abstract available
    
    

    
    Exp Clin Transplant

22. TUNC M, Tekelioglu T, Akbay NA, Akilli H, et al
    Atypical Cervical Cytology in Solid-Organ Transplant Patients: 20 Years of Experience in a Single Center.
    Exp Clin Transplant. 2025;23:583-586.
    PubMed         Abstract available
    
    

    
    Fam Pract

23. BAI Y, Devlin RA, Habbous S, Jaakkimainen L, et al
    Physician payment models and preventive cancer screening: a population-based retrospective cohort analysis from Ontario, Canada.
    Fam Pract. 2025;42:cmaf076.
    PubMed         Abstract available
    
    

    
    Front Cell Dev Biol

24. CHEN X, Zheng L, Zeng X, Pan N, et al
    The potential role of miR-155 in the tumorigenesis of cervical cancer.
    Front Cell Dev Biol. 2025;13:1572373.
    PubMed         Abstract available
    
    

    
    Front Cell Infect Microbiol

25. BAUTISTA J, Altamirano-Colina A, Lopez-Cortes A
    The vaginal microbiome in HPV persistence and cervical cancer progression.
    Front Cell Infect Microbiol. 2025;15:1634251.
    PubMed         Abstract available
    
    

    
    Front Endocrinol (Lausanne)

26. ZHANG Y, Zhang J, Li H, Zhuang Y, et al
    Synergistic impact of dysglycemia and HPV on cervical cancer risk: a potential mediating role of Ki-67.
    Front Endocrinol (Lausanne). 2025;16:1422881.
    PubMed         Abstract available
    
    

    
    Front Microbiol

27. SISODIYA S, Singh P, Joshi T, Aftab M, et al
    Human papillomavirus-mediated cervical cancer: epigenetic interplay and clinical implications.
    Front Microbiol. 2025;16:1633283.
    PubMed         Abstract available
    
    

    
    Front Mol Biosci

28. 
    Retraction: Corrigendum: CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study.
    Front Mol Biosci. 2025;12:1712894.
    PubMed         Abstract available
    
    
29. 
    Retraction: CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study.
    Front Mol Biosci. 2025;12:1712893.
    PubMed         Abstract available
    
    

    
    Front Oncol

30. YANG T, Yi Q, Gong J
    Multiparametric magnetic resonance imaging-based comprehensive model on prediction of lymphovascular space invasion in cervical cancer.
    Front Oncol. 2025;15:1578119.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

31. SAYED NADY D, Abdel-Halim SA, Hegazy MF, Aljohani S, et al
    In Vitro antiproliferative potential of essential oil extract from Carica papaya L. seeds against cervical cancer.
    Front Pharmacol. 2025;16:1676006.
    PubMed         Abstract available
    
    
32. LI M, Gao N, Xu L, Ge P, et al
    Integrative RNA-seq and LASSO-COX analysis reveal Paeonol's key target gene in proliferation suppression and apoptosis-induced in cervical cancer.
    Front Pharmacol. 2025;16:1646473.
    PubMed         Abstract available
    
    

    
    Funct Integr Genomics

33. WANG Q, Yu H, Huang R
    FAM72A promotes cervical cancer progression by regulating the PI3K pathway.
    Funct Integr Genomics. 2025;25:215.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol Rep

34. WESTERHOFF T, Baudoux N, Undurraga M, Petignat P, et al
    Durable complete response with chemo-immuno-radiotherapy for metastatic cervical cancer progressing under immunotherapy: a case series.
    Gynecol Oncol Rep. 2025;61:101967.
    PubMed         Abstract available
    
    

    
    Health Care Women Int

35. BOLUKBASI FB, Sahin B
    Determinants of cervical cancer incidence and mortality: A study on WHO countries.
    Health Care Women Int. 2025 Oct 21:1-22. doi: 10.1080/07399332.2025.2573648.
    PubMed         Abstract available
    
    

    
    J Biomed Sci

36. JIANG H, Liu L, He S, Qu S, et al
    Dimethyl fumarate reprograms cervical cancer cells to enhance antitumor immunity by activating mtDNA-cGAS-STING pathway.
    J Biomed Sci. 2025;32:92.
    PubMed         Abstract available
    
    

    
    J Formos Med Assoc

37. TSAI YL, Wang HJ, Chen SI, Chang JY, et al
    Impact of COVID-19 on cervical cancer screening: A cohort study.
    J Formos Med Assoc. 2025 Oct 22:S0929-6646(25)00574.
    PubMed         Abstract available
    
    

    
    J Natl Med Assoc

38. RUAN Y, Liu X, Li Y, Fu A, et al
    A risk prediction model for cervical cancer in adults: A study based on the national health interview survey (NHIS) 2019-2023.
    J Natl Med Assoc. 2025 Oct 22:S0027-9684(25)00330.
    PubMed         Abstract available
    
    

    
    J Virol Methods

39. SCOTT H, Kamraoui I, White MPJ, Davis C, et al
    Reference gene evaluation for digital PCR; Applications for RNA biomarker testing in cervical precancer.
    J Virol Methods. 2026;339:115268.
    PubMed         Abstract available
    
    

    
    JAMA Netw Open

40. AMBOREE TL, Adsul P, Damgacioglu H, Schmeler KM, et al
    National Outcomes of Increasing Cervical Cancer Screening in Federally Qualified Health Centers.
    JAMA Netw Open. 2025;8:e2538593.
    PubMed         Abstract available
    
    

    
    JCO Glob Oncol

41. FALLAH PN, Medley N, Birara Fanta M, Shaki MH, et al
    Challenges and Opportunities in the Treatment of Invasive Cervical Cancer in Low-Resource Settings: A Survey of the International Gynecologic Cancer Society Fellowship Programs.
    JCO Glob Oncol. 2025;11:e2500015.
    PubMed         Abstract available
    
    

    
    Lancet Glob Health

42. HYATT A, Canfell K, Moodie R, Aranda S, et al
    Achieving cervical cancer elimination: an ecological assessment of global determinants using a policy determinant model.
    Lancet Glob Health. 2025;13:e1828-e1836.
    PubMed         Abstract available
    
    
43. AMANI A, Bloem P, Kobayashi E, Atuhaire B, et al
    Scaling HPV vaccination in Africa to eliminate cervical cancer by 2030.
    Lancet Glob Health. 2025 Oct 14:S2214-109X(25)00349.
    PubMed        
    
    

    
    Med Oncol

44. LI C, Zhu Y, Li N, Dai B, et al
    Topical vaginal drug therapy in cervical cancer management: a review of clinical trials and preclinical evidence.
    Med Oncol. 2025;42:523.
    PubMed         Abstract available
    
    
45. DALVI SD, Ratnaparkhi MP, Badhe RN, Matkar BS, et al
    Targeted drug delivery in cervical carcinoma: the role of gold nanoparticles in enhancing treatment efficacy.
    Med Oncol. 2025;42:522.
    PubMed         Abstract available
    
    

    
    Mod Pathol

46. KURITA Y, Meguro S, Sugiura Y, Togo S, et al
    Whole Slide Imaging-Free Supporting Tool for Cytotechnologists in Cervical Cytology.
    Mod Pathol. 2025;38:100817.
    PubMed         Abstract available
    
    

    
    Mol Cancer

47. CHEN F, Bai G, Liu Q, He G, et al
    Integrated multi-omics identifies a CD54(+) iCAF-ITGAL(+) macrophage niche driving immunosuppression via CXCL8-PDL1 axis in cervical cancer.
    Mol Cancer. 2025;24:262.
    PubMed         Abstract available
    
    

    
    Mol Carcinog

48. WANG Y, Li H, Tian S, Sun J, et al
    SLC5A6 Regulates Lipid Metabolism and Lymph Node Metastasis in Cervical Cancer via FASN.
    Mol Carcinog. 2025 Oct 18. doi: 10.1002/mc.70052.
    PubMed         Abstract available
    
    

    
    Naunyn Schmiedebergs Arch Pharmacol

49. FATIMA S, Verma M, Shahab U, Ahmad S, et al
    Cimicifugic acid B, a hydroxycinnamic acid ester of Cimicifuga sp., exhibits strong antiproliferative and cytotoxic potential against cervical cancer cells.
    Naunyn Schmiedebergs Arch Pharmacol. 2025.
    PubMed         Abstract available
    
    

    
    Noncoding RNA Res

50. LI Q, Zhou Z, Li X, Lan Q, et al
    LncRNA-EME1 enhances BRCA1 recruitment and alters repair of DNA damage in cervical cancer radioresistance.
    Noncoding RNA Res. 2025;16:57-69.
    PubMed         Abstract available
    
    

    
    PEC Innov

51. BOATMAN D, Jarrett Z, Ashcraft AM, Haggerty T, et al
    Community co-design of research intervention materials to reduce cervical cancer disparities in Appalachia.
    PEC Innov. 2025;7:100434.
    PubMed         Abstract available
    
    

    
    Philos Ethics Humanit Med

52. HUANG LL
    Medical futility and the ethics of continuing treatment: a hermeneutic inquiry into patient and physician perspectives.
    Philos Ethics Humanit Med. 2025;20:33.
    PubMed         Abstract available
    
    

    
    Public Health

53. PENA-MANRIQUE I, Maclin BJ, Kreimer AR, Alraqiq H, et al
    Knowledge that HPV can cause oropharyngeal cancer and cervical cancer among adults in the United States: A comparison of prevalence and predictors.
    Public Health. 2025;249:106006.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

54. ROSSI L, Nout R, Heijmen B
    Response to letter to editor "Re-evaluating 'Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy': The silent cumulative CTVIR deficit".
    Radiother Oncol. 2025 Oct 21:111217. doi: 10.1016/j.radonc.2025.111217.
    PubMed        
    
    
55. FANG S, Gao M
    Re-evaluating 'Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy': The silent cumulative CTVIR deficit.
    Radiother Oncol. 2025 Oct 19:111216. doi: 10.1016/j.radonc.2025.111216.
    PubMed        
    
    

    
    Rev Esp Patol

56. GRACIA SAENZ L, Shalygina S, Roca R, Ortuno S, et al
    Identification of germline mutations in DICER1 through routine somatic NGS analysis in various neoplasms.
    Rev Esp Patol. 2025;58:100834.
    PubMed         Abstract available
    
    

    
    Sci Rep

57. LI S, Li H, Li Y, Cui Y, et al
    miR-378, miR-20a, and miR-520a-3p can be used in a novel serum prognostic panel for cervical cancer.
    Sci Rep. 2025;15:36410.
    PubMed         Abstract available
    
    
58. SARANYA SS, Santhanakrishnan C, Kumar KPM, Kumar PA, et al
    Advancements in fusion-based deep representation learning for enhanced cervical precancerous lesion classification using biomedical image analysis.
    Sci Rep. 2025;15:36705.
    PubMed         Abstract available
    
    
59. MILI MA, Hossain MJ, Poli MA, Kumar SB, et al
    Impact of health education on knowledge and perception of cervical cancer and screening among rural women in Bangladesh.
    Sci Rep. 2025;15:36812.
    PubMed         Abstract available
    
    
60. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Self efficacy as a key mediator for cervical cancer screening behavior.
    Sci Rep. 2025;15:37090.
    PubMed         Abstract available
    
    

    
    Strahlenther Onkol

61. PEKYUREK VARAN M, Yaprak G, Gunduz K, Yetmen Dogan O, et al
    Investigation of potential biomarkers associated with relapse in cervical cancer: miRNA-320a-3p and miRNA-136-5p.
    Strahlenther Onkol. 2025 Oct 23. doi: 10.1007/s00066-025-02476.
    PubMed         Abstract available
    
    

    
    Vaccine

62. CAO X, Borah P, Lee DKL, Vishnevskaya A, et al
    Beyond the post: The impact of politized anti-vaccine misinformation comments and challenges of correction on social media.
    Vaccine. 2025;65:127760.
    PubMed         Abstract available
    
    

    
    Virchows Arch

63. KIR G, Erbagci A, Ozen F, Sayit D, et al
    HPV-independent squamous sell carcinoma of cervix: a clinicopathological, immunohistochemical, and molecular analysis of six cases.
    Virchows Arch. 2025;487:775-786.
    PubMed         Abstract available
    
    

    
    Virol J

64. ZHUOYAO L, Xiaohan W, Xinyu M, Songling Z, et al
    The co-regulation of HPV infection by vaginal microbiota and the immune system.
    Virol J. 2025;22:334.
    PubMed         Abstract available
    
    
65. ZHU X, Li S, Zhuang C
    Prevalence characteristics of human papillomavirus among women in Henan Province of China.
    Virol J. 2025;22:332.
    PubMed         Abstract available
    
    

    
    World J Surg Oncol

66. XU L, Huang S, Zhu H
    A case report on SMARCA4 deficient cervical adenocarcinoma with high-grade squamous intraepithelial lesion.
    World J Surg Oncol. 2025;23:384.
    PubMed         Abstract available
    
    

    
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

67. HU Y, Wang Z, Li F, Feng W, et al
    [The effect of CD33(+)MDSC-mediated T lymphocyte function on the therapeutic efficacy of (125)I particle implantation combined with arterial chemoembolization in the treatment of cervical cancer].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2025;41:905-912.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.